Phase III clinical trial of Jusvinza for treating rheumatoid arthritis is progressing
This placebo-controlled, double-blind trial includes patients with moderate rheumatoid arthritis
47 resultados.
This placebo-controlled, double-blind trial includes patients with moderate rheumatoid arthritis
The Center for Immunoassay (CIE) and the Beijing Institute of Technology (BIT) signed in Havana a memorandum of understanding for the creation of a joint laboratory in the Asian country, focused on expanding academic scientific collaboration
After receiving authorization from the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) and approval from the Ministry of Public Health, a phase II-III clinical trial began at the Institute of Hematology and Immunology
Fidel inaugurated the Center for Genetic Engineering and Biotechnology in 1986, where interferon was first produced 39 years ago, now playing a key role in the COVID-19 battle
Just months after Cuba detected its first positive case of COVID-19, the country already had a specific vaccine candidate—exactly five years ago today
Cuban scientist reports that, in a small study, the survival rate for patients in serious and critical condition treated with CIGB-258 was 81%
Cuban women are on the front lines of the COVID-19 battle, participating in the development of new treatment protocols, conducting critical research, and leading clinical trials of four candidate vaccines
Currently, the Finlay Vaccine Institute is accelerating the development of the candidates Quimi-Vio 11 (in phase II-III clinical trials) and Quimi-Vio 16, with the aim of protecting the most vulnerable population through conjugation technology of proven efficacy and safety
A total of 323 plants had been identified as invasive alien species in Cuba, which have the potential to impact biological diversity and affect agricultural production
The 15th International Convention on Environment and Development is taking place at the Convention Palace until July 5